BDF
CAPR icon

Black Diamond Financial’s Capricor Therapeutics CAPR Stock Holding History

Black Diamond Financial’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.4M Hold
79,077
– – 0.26% 51
2025
Q4 		$2.28M Sell
79,077
-198,660
-72% -$2.59M 0.24% 56
2025
Q3 		$2M Hold
277,737
– – 0.22% 57
2025
Q2 		$2.76M Hold
277,737
– – 0.43% 42
2025
Q1 		$2.64M Hold
277,737
– – 0.4% 42
2024
Q4 		$3.83M Buy
+277,737
New +$4.87M 0.57% 42

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Black Diamond Financial's CAPR Position: Q1 2026 in Review

Black Diamond Financial held its Capricor Therapeutics (CAPR) position steady in Q1 2026 at 79,077 shares worth $2.4M. The position accounts for 0.26% of the portfolio, ranked #51.

Black Diamond Financial first reported a position in CAPR in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.83M in Q4 2024. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Black Diamond Financial held 79,077 shares of Capricor Therapeutics worth $2.4M as of Q1 2026.
  • Black Diamond Financial left its Capricor Therapeutics share count unchanged in Q1 2026.
  • Capricor Therapeutics made up 0.26% of Black Diamond Financial's portfolio in Q1 2026, its #51 holding.
  • Black Diamond Financial first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Black Diamond Financial's Capricor Therapeutics position peaked at $3.83M in Q4 2024.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Black Diamond Financial's 13F filing for Q1 2026, filed 5 May 2026.